Indoco Remedies Limited
Stock Forecast, Prediction & Price Target
Indoco Remedies Limited Financial Estimates
Indoco Remedies Limited Revenue Estimates
Indoco Remedies Limited EBITDA Estimates
Indoco Remedies Limited Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 3/31/2021 | 3/31/2022 | 3/31/2024 | 3/31/2026 | |||
Revenue
% change YoY
| ₹12.18B N/A | ₹15.03B 23.39% | ₹17.88B 18.91% | Avg: ₹21.87B Low: ₹21.24B High: ₹22.73B avg. 22.35% | |||
Net Income
% change YoY
| ₹930.45M N/A | ₹1.54B 66.37% | ₹984.60M -36.39% | Avg: ₹1.75B Low: ₹1.55B High: ₹1.92B avg. 78.32% | |||
EBITDA
% change YoY
| ₹2.27B N/A | ₹3.32B 46.34% | ₹2.64B -20.39% | Avg: ₹3.72B Low: ₹3.62B High: ₹3.87B avg. 40.90% | |||
EPS
% change YoY
| $10.1 N/A | $16.8 66.33% | $10.51 -37.44% | Avg: $19.08 Low: $16.9 High: $20.9 avg. 81.54% | |||
Operating Expenses
% change YoY
| ₹7.01B N/A | ₹8.21B 17.04% | ₹10.84B 32.05% | Avg: ₹3.75B Low: ₹3.64B High: ₹3.89B avg. -65.40% | |||
FAQ
What is Indoco Remedies Limited stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 78.32% in 2026-2026.
We have gathered data from 4 analysts. Their low estimate is 1.55B, average is 1.75B and high is 1.92B.
What is Indoco Remedies Limited stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 22.35% in 2026-2026.
We have gathered data from 4 analysts. Their low revenue estimate is ₹21.24B, average is ₹21.87B and high is ₹22.73B.
What is Indoco Remedies Limited stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 81.54% in 2026-2026.
We have gathered data from 4 analysts. Their low earnings per share estimate is $16.9, average is $19.08 and high is ₹20.9.